Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Circulation Research
|
February 16, 2008
Glycosylation of thrombin activatable fibrinolysis inhibitor: why is it so important?
Federico Biscetti
Circulation Research
|
July 4, 2008
Endothelial progenitor cells and angiogenesis join the PPARty
Federico Biscetti, Roberto Pola
Critical Care Medicine
|
September 20, 2011
Screening of multidrug-resistant bacteria in high-risk patients: an ongoing discussion
Giulia De Angelis, Federico Biscetti
Critical Care Medicine
|
January 29, 2013
Do not tell the children: toothbrushing does not make a difference (in your ventilator-associated pneumonia rates)
Giulia De Angelis, Federico Biscetti
Current Vascular Pharmacology
|
July 10, 2015
New therapeutic effects of cilostazol in patients with ischemic disorders
Federico Biscetti, Gianfranco Ferraccioli, Andrea Flex
Current Vascular Pharmacology
|
June 23, 2011
Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration
Federico Biscetti, Giovanni Ghirlanda, Andrea Flex
Frontiers in Endocrinology
|
April 2, 2025
Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, volume III
Maria Margherita Rando, Federico Biscetti, Andrea Flex
Vascular Medicine (London, England)
|
January 16, 2009
Images in vascular medicine. Parkes Weber syndrome: bone involvement visualized by computed tomography angiography
Giuseppe Straface, Federico Biscetti, Giovanni Ghirlanda, et al.
Internal and Emergency Medicine
|
October 11, 2019
Internists feel the rhythm
Federico Biscetti, Maria Anna Nicolazzi, Andrea Flex, et al.
Frontiers in Endocrinology
|
September 19, 2022
Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
Maria Margherita Rando, Martina Guthoff, Vinod Tiwari, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Circulation Research
|
February 16, 2008
Glycosylation of thrombin activatable fibrinolysis inhibitor: why is it so important?
Federico Biscetti
Circulation Research
|
July 4, 2008
Endothelial progenitor cells and angiogenesis join the PPARty
Federico Biscetti, Roberto Pola
Critical Care Medicine
|
September 20, 2011
Screening of multidrug-resistant bacteria in high-risk patients: an ongoing discussion
Giulia De Angelis, Federico Biscetti
Critical Care Medicine
|
January 29, 2013
Do not tell the children: toothbrushing does not make a difference (in your ventilator-associated pneumonia rates)
Giulia De Angelis, Federico Biscetti
Current Vascular Pharmacology
|
July 10, 2015
New therapeutic effects of cilostazol in patients with ischemic disorders
Federico Biscetti, Gianfranco Ferraccioli, Andrea Flex
Current Vascular Pharmacology
|
June 23, 2011
Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration
Federico Biscetti, Giovanni Ghirlanda, Andrea Flex
Frontiers in Endocrinology
|
April 2, 2025
Editorial: Diagnosis, prevention and treatment in diabetic nephropathy, volume III
Maria Margherita Rando, Federico Biscetti, Andrea Flex
Vascular Medicine (London, England)
|
January 16, 2009
Images in vascular medicine. Parkes Weber syndrome: bone involvement visualized by computed tomography angiography
Giuseppe Straface, Federico Biscetti, Giovanni Ghirlanda, et al.
Internal and Emergency Medicine
|
October 11, 2019
Internists feel the rhythm
Federico Biscetti, Maria Anna Nicolazzi, Andrea Flex, et al.
Frontiers in Endocrinology
|
September 19, 2022
Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
Maria Margherita Rando, Martina Guthoff, Vinod Tiwari, et al.
Page
of 7